Bořivoj Vojtěšek
- Molecular Biology top 0.5%
- Oncology top 0.2%
- Cancer Research top 0.5%
- Cell Biology top 0.5%
- Epidemiology top 2%
- Co-authors
- David P. LaneRoman HrstkaJiří BártekPetr MüllerPhilip J. CoatesCarol MidgleyJan KovaříkTed R. Hupp
- Topics
- Cancer-related Molecular Pathways (125 papers)Cancer Research and Treatments (48 papers)Ubiquitin and proteasome pathways (31 papers)
- Cited by
- OncologyBiotechnologyCancer Research
- Partner nations
- CzechiaUnited KingdomPoland
In The Last Decade
Bořivoj Vojtěšek
297 papers receiving 10.6k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Molecular Biology 6.4k
- Oncology 5.0k
- Cancer Research 1.7k
- Cell Biology 1.2k
- Epidemiology 1.1k
Countries citing papers authored by Bořivoj Vojtěšek
This map shows the geographic impact of Bořivoj Vojtěšek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bořivoj Vojtěšek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bořivoj Vojtěšek more than expected).
Fields of papers citing papers by Bořivoj Vojtěšek
This network shows the impact of papers produced by Bořivoj Vojtěšek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bořivoj Vojtěšek. The network helps show where Bořivoj Vojtěšek may publish in the future.
Co-authorship network of co-authors of Bořivoj Vojtěšek
This figure shows the co-authorship network connecting the top 25 collaborators of Bořivoj Vojtěšek. A scholar is included among the top collaborators of Bořivoj Vojtěšek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bořivoj Vojtěšek. Bořivoj Vojtěšek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 5 | |
| 3 | 3 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 9 | |
| 8 | 1 | |
| 9 | 16 | |
| 10 | 26 | |
| 11 | 56 | |
| 12 | Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients | 1 |
| 13 | 25 | |
| 14 | 22 | |
| 15 | 123 | |
| 16 | 18 | |
| 17 | Using Markers to Aid Decision Making in Diagnostics | 1 |
| 18 | 107 | |
| 19 | 1 | |
| 20 | 25 |
About Bořivoj Vojtěšek
Bořivoj Vojtěšek is a scholar working on Oncology, Biotechnology and Cancer Research, having authored 314 papers that have together received 10.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (125 papers), Cancer Research and Treatments (48 papers) and Ubiquitin and proteasome pathways (31 papers). The work is most often cited by research in Oncology (5.0k citations), Biotechnology (1.1k citations) and Cancer Research (1.7k citations). Bořivoj Vojtěšek has collaborated with scholars based in Czechia, United Kingdom and Poland. Frequent co-authors include David P. Lane, Roman Hrstka, Jiří Bártek, Petr Müller, Philip J. Coates, Carol Midgley, Jan Kovařík, Ted R. Hupp, Rudolf Nenutil and Jiřina Bártková. Their work appears in journals such as The Lancet, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.